首页 > 最新文献

Journal of Indian System of Medicine最新文献

英文 中文
A chronic case of Bell’s palsy and its management through Ayurveda: case study 慢性贝尔氏麻痹病例及其通过阿育吠陀治疗:案例研究
Pub Date : 2021-10-01 DOI: 10.4103/jism.jism_52_21
Preeti Patel, Swarnakant Jena, Santosh Bhatted, Prasanth Dharmarajan
Background: Bell’s palsy is an acute idiopathic condition that develops due to peripheral facial nerve paralysis of sudden onset, usually affecting the face by temporary weakness or paralysis of the face. With various aetiologies (infection, trauma, ischemia, or inflammation) affecting the seventh cranial nerve are the pathogenesis to originating the symptoms of Bells’s palsy. According to Ayurveda, this condition can be correlated with Ardita Vata, which is described under the umbrella of Vatavyadhi Chikitsa. Aim and Objectives: The study has been documented to evaluate the efficacy of Panchakarma procedures along with Shamana Aushadhi (oral medication) in the management of a patient with chronic Bell’s palsy. Settings: A 1-year-old chronic case of Bell’s palsy was managed in out patient department-based Panchakarma treatment at AIIA, New Delhi, and the patient was assessed both before and after the given treatment. Treatment Plan: The patient was administered Mukhabhyanga (massage on face) with Asana Bilwadi Taila, Nadi Sweda (sudation) with Dashamoola Ksheer Dhooma, Nasya (transnasal medication) with Avartita Ksheerbala Taila in Arohana Matra (increasing dose), and Kavala (Gargling) with Saindhavadi Taila and Irimedadi Taila for 14 days along with Shamana medication for one month. Result: Marked improvement was observed on the basis of House–Brackmann scale; continuous teardrops from the eye were completely stopped. After 15 days of treatment, the scale was reduced from IV to III, and then II, I, respectively after the 30th day and 60th day during the follow-up. Conclusion: This case showed promising and quick results of Ayurveda treatment by considering aspects of Vatavyadhi, specifically Ardita Vata, even after 1 year of chronicity without showing any complications.
背景:贝尔麻痹是一种突发性面神经末梢麻痹引起的急性特发性疾病,通常通过面部暂时性无力或瘫痪影响面部。影响第七脑神经的各种病因(感染、创伤、缺血或炎症)是引起贝尔氏麻痹症状的发病机制。根据阿育吠陀,这种情况可以与阿迪塔瓦塔相关,这是在瓦塔瓦迪奇基萨的伞下描述的。目的和目的:本研究旨在评估Panchakarma手术和Shamana Aushadhi(口服药物)治疗慢性贝尔氏麻痹患者的疗效。研究背景:在新德里AIIA的门诊Panchakarma治疗中,对1岁的慢性贝尔麻痹患者进行了治疗,并在治疗前后对患者进行了评估。治疗方案:患者接受Mukhabhyanga(面部按摩)配合Asana Bilwadi Taila, Nadi Sweda(通气)配合Dashamoola Ksheer Dhooma, Nasya(经鼻用药)配合Avartita Ksheerbala Taila在Arohana Matra(增加剂量),Kavala(漱口)配合Saindhavadi Taila和Irimedadi Taila,持续14天,同时服用Shamana药物一个月。结果:以House-Brackmann量表为基础,有明显改善;眼睛里连续不断的泪珠被完全止住了。治疗15天后,在随访第30天和第60天后,量表由IV降至III,再由II降至I。结论:该病例通过考虑Vatavyadhi的各个方面,特别是Ardita Vata,即使在1年的慢性发作后也没有出现任何并发症,显示出阿育吠陀治疗有希望和快速的结果。
{"title":"A chronic case of Bell’s palsy and its management through Ayurveda: case study","authors":"Preeti Patel, Swarnakant Jena, Santosh Bhatted, Prasanth Dharmarajan","doi":"10.4103/jism.jism_52_21","DOIUrl":"https://doi.org/10.4103/jism.jism_52_21","url":null,"abstract":"Background: Bell’s palsy is an acute idiopathic condition that develops due to peripheral facial nerve paralysis of sudden onset, usually affecting the face by temporary weakness or paralysis of the face. With various aetiologies (infection, trauma, ischemia, or inflammation) affecting the seventh cranial nerve are the pathogenesis to originating the symptoms of Bells’s palsy. According to Ayurveda, this condition can be correlated with Ardita Vata, which is described under the umbrella of Vatavyadhi Chikitsa. Aim and Objectives: The study has been documented to evaluate the efficacy of Panchakarma procedures along with Shamana Aushadhi (oral medication) in the management of a patient with chronic Bell’s palsy. Settings: A 1-year-old chronic case of Bell’s palsy was managed in out patient department-based Panchakarma treatment at AIIA, New Delhi, and the patient was assessed both before and after the given treatment. Treatment Plan: The patient was administered Mukhabhyanga (massage on face) with Asana Bilwadi Taila, Nadi Sweda (sudation) with Dashamoola Ksheer Dhooma, Nasya (transnasal medication) with Avartita Ksheerbala Taila in Arohana Matra (increasing dose), and Kavala (Gargling) with Saindhavadi Taila and Irimedadi Taila for 14 days along with Shamana medication for one month. Result: Marked improvement was observed on the basis of House–Brackmann scale; continuous teardrops from the eye were completely stopped. After 15 days of treatment, the scale was reduced from IV to III, and then II, I, respectively after the 30th day and 60th day during the follow-up. Conclusion: This case showed promising and quick results of Ayurveda treatment by considering aspects of Vatavyadhi, specifically Ardita Vata, even after 1 year of chronicity without showing any complications.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"33 1","pages":"272 - 277"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87978333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anatomical and genetic identification of two Euphorbia species 两种大戟属植物的解剖和遗传鉴定
Pub Date : 2021-10-01 DOI: 10.4103/jism.jism_1_21
Rabina Acharya, Sudipta Roy, C. Harisha, S. Hegde, A. Ranade
Background: Euphorbia antiquorum L. and Euphorbia neriifolia L. belong to the family Euphorbiaceae. E. antiquorum and E. neriifolia are considered as botanical source of Tridhara Snuhi and Snuhi, respectively. E. antiquorum has been reported for its anticancer effect in different cancer cell lines and E. neriifolia is traditionally used in the management of digestive problem, respiratory problem, etc. The present study was designed to evaluate anatomical and genetic characterization of E. antiquorum and E. neriifolia. Material and Methods: Anatomical evaluation was assessed through macroscopic and microsopic evaluation of stem and leaf of both the plants, whereas genetic characterization was examined through DNA barcoding analysis of leaf sample of both the plants. Result: Both plants are xerophytic in nature and bear a good amount of milky white latex, and shrub to small tree in nature. Microscopically, stem and leaf of both the plants contain latex duct in transverse section. All these characters highlights the key characters of family Euphorbiaceae. DNA barcoding confirms the molecular identity of both the plants. Conclusion: Data specified in the present study regarding anatomical and genetic characters will help for easy identification of both the plants, that is, Euphorbia antiquorum L. and Euphorbia neriifolia L.
背景:大戟(Euphorbia antiquorum L.)和大戟属大戟科。黄芪和黄芪分别被认为是黄芪和黄芪的植物来源。据报道,鸢尾草在不同的癌细胞系中具有抗癌作用,鸢尾草传统上用于治疗消化问题、呼吸问题等。本研究的目的是为了评估的解剖和遗传特征的黄花和黄花。材料与方法:通过对两种植物茎叶的宏观和微观评价进行解剖鉴定,通过对两种植物叶片样品的DNA条形码分析进行遗传鉴定。结果:两种植物均为旱生植物,产乳白色乳胶量大,属灌木至小树。显微镜下,两种植物的茎和叶的横切面上都含有乳胶管。这些特征突出了大戟科的主要特征。DNA条形码证实了这两种植物的分子身份。结论:本研究提供的解剖和遗传性状数据有助于对大戟和细叶大戟的鉴别。
{"title":"Anatomical and genetic identification of two Euphorbia species","authors":"Rabina Acharya, Sudipta Roy, C. Harisha, S. Hegde, A. Ranade","doi":"10.4103/jism.jism_1_21","DOIUrl":"https://doi.org/10.4103/jism.jism_1_21","url":null,"abstract":"Background: Euphorbia antiquorum L. and Euphorbia neriifolia L. belong to the family Euphorbiaceae. E. antiquorum and E. neriifolia are considered as botanical source of Tridhara Snuhi and Snuhi, respectively. E. antiquorum has been reported for its anticancer effect in different cancer cell lines and E. neriifolia is traditionally used in the management of digestive problem, respiratory problem, etc. The present study was designed to evaluate anatomical and genetic characterization of E. antiquorum and E. neriifolia. Material and Methods: Anatomical evaluation was assessed through macroscopic and microsopic evaluation of stem and leaf of both the plants, whereas genetic characterization was examined through DNA barcoding analysis of leaf sample of both the plants. Result: Both plants are xerophytic in nature and bear a good amount of milky white latex, and shrub to small tree in nature. Microscopically, stem and leaf of both the plants contain latex duct in transverse section. All these characters highlights the key characters of family Euphorbiaceae. DNA barcoding confirms the molecular identity of both the plants. Conclusion: Data specified in the present study regarding anatomical and genetic characters will help for easy identification of both the plants, that is, Euphorbia antiquorum L. and Euphorbia neriifolia L.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"34 1","pages":"252 - 258"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90433048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prakriti (constitution of body) and nutritional status in children: An exploratory study 儿童体质与营养状况的探索性研究
Pub Date : 2021-10-01 DOI: 10.4103/jism.jism_79_21
R. Kulkarni, C. Manoj, C. Srilakshmi
Introduction: Prakriti (constitution of body) signifies individuality and determines the prevention, diagnosis, and treatment of diseases. It is a unique trait that is specific to individuals and it is determined at conception based on the predominance of dosha. Vataja, Pittaja, Kaphaja, Vata pitta, Pittakapha, Kaphavata, and Sannipataja are the seven types of Prakriti described in the classics. Nutritional status is the reflection of the quality of health as a result of a nutritious diet consumed and its optimum utilization in the body. prakriti influences individuals’ nutritional status via digestion; their metabolism; and also their physical, mental, and emotional characteristics. Aim: The aim of this study was to assess the impact of prakriti on the nutritional status of children aged 5–10 years. Materials and Methods: Children aged 5–10 years visiting an Ayurveda hospital for a routine health checkup were screened with a standard prakriti questionnaire. Their nutritional status was assessed in terms of their height, weight, waist circumference, hip circumference, waist-to-hip ratio, and BMI. Prakriti in relation to nutritional status was analyzed by using SPSS 20. Results: Among the 573 children screened, 22 children (3.8%) were of Vata prakriti, three children (0.5%) Pitta prakriti, 31(5.4%) Kapha prakriti, 97 (16.9%) Vata pitta, a maximum of 260 (45.3%) Vatakapha, and 160 (27.9%) Pittakapha prakriti. On analysis of nutritional status, 85 children were observed to be malnourished (14.8%), 125 underweight (21.8%), 215 normal (37.5%), 62 overweight (10.8%), and 86 obese (15.1%). Conclusion: The majority of children belonged to Dwandwa prakriti, especially Kapha dominant. Most children with Kapha dominance were well nourished and had a tendency of being overweight as compared with others. Children with Pitta predominant Prakriti were moderately nourished and had excellent metabolic activity, leading to a less chance for being overweight. Nutritional status correlates well with the Prakriti descriptions.
简介:Prakriti(身体的构成)象征着个性,决定着疾病的预防、诊断和治疗。这是一种独特的特质,是特定于个人的,它是在基于dosha优势的基础上确定的。Vataja、Pittaja、Kaphaja、Vata pitta、Pittakapha、Kaphavata和Sannipataja是经典中描述的七种Prakriti。营养状况是健康质量的反映,这是摄入营养饮食及其在体内得到最佳利用的结果。Prakriti通过消化影响个体的营养状况;他们的新陈代谢;以及他们的身体、心理和情感特征。目的:本研究的目的是评估prakriti对5-10岁儿童营养状况的影响。材料和方法:采用标准的prakriti问卷对5-10岁的阿育吠陀医院例行健康检查的儿童进行筛选。根据他们的身高、体重、腰围、臀围、腰臀比和BMI来评估他们的营养状况。利用SPSS 20分析Prakriti与营养状况的关系。结果:573例患儿中,Vata prakriti患儿22例(3.8%),Pitta prakriti患儿3例(0.5%),Kapha prakriti患儿31例(5.4%),Vata prakriti患儿97例(16.9%),Vatakapha最多260例(45.3%),Pittakapha prakriti患儿160例(27.9%)。营养状况分析中,营养不良85例(14.8%),体重不足125例(21.8%),正常215例(37.5%),超重62例(10.8%),肥胖86例(15.1%)。结论:儿童多属Dwandwa型,以Kapha型为主。与其他儿童相比,大多数卡法优势儿童营养良好,并且有超重的倾向。以皮塔为主的Prakriti儿童营养适度,代谢活动良好,导致超重的可能性较小。营养状况与Prakriti的描述密切相关。
{"title":"Prakriti (constitution of body) and nutritional status in children: An exploratory study","authors":"R. Kulkarni, C. Manoj, C. Srilakshmi","doi":"10.4103/jism.jism_79_21","DOIUrl":"https://doi.org/10.4103/jism.jism_79_21","url":null,"abstract":"Introduction: Prakriti (constitution of body) signifies individuality and determines the prevention, diagnosis, and treatment of diseases. It is a unique trait that is specific to individuals and it is determined at conception based on the predominance of dosha. Vataja, Pittaja, Kaphaja, Vata pitta, Pittakapha, Kaphavata, and Sannipataja are the seven types of Prakriti described in the classics. Nutritional status is the reflection of the quality of health as a result of a nutritious diet consumed and its optimum utilization in the body. prakriti influences individuals’ nutritional status via digestion; their metabolism; and also their physical, mental, and emotional characteristics. Aim: The aim of this study was to assess the impact of prakriti on the nutritional status of children aged 5–10 years. Materials and Methods: Children aged 5–10 years visiting an Ayurveda hospital for a routine health checkup were screened with a standard prakriti questionnaire. Their nutritional status was assessed in terms of their height, weight, waist circumference, hip circumference, waist-to-hip ratio, and BMI. Prakriti in relation to nutritional status was analyzed by using SPSS 20. Results: Among the 573 children screened, 22 children (3.8%) were of Vata prakriti, three children (0.5%) Pitta prakriti, 31(5.4%) Kapha prakriti, 97 (16.9%) Vata pitta, a maximum of 260 (45.3%) Vatakapha, and 160 (27.9%) Pittakapha prakriti. On analysis of nutritional status, 85 children were observed to be malnourished (14.8%), 125 underweight (21.8%), 215 normal (37.5%), 62 overweight (10.8%), and 86 obese (15.1%). Conclusion: The majority of children belonged to Dwandwa prakriti, especially Kapha dominant. Most children with Kapha dominance were well nourished and had a tendency of being overweight as compared with others. Children with Pitta predominant Prakriti were moderately nourished and had excellent metabolic activity, leading to a less chance for being overweight. Nutritional status correlates well with the Prakriti descriptions.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"73 1","pages":"247 - 251"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80960200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurveda interventions in management of chronic plaque psoriasis (Ekakushtha) 阿育吠陀治疗慢性斑块型银屑病
Pub Date : 2021-10-01 DOI: 10.4103/jism.jism_62_21
Meenakshi Sharma, S. Mandal, Anil Kumar
Psoriasis is a chronic inflammatory disease skin disease that is associated with different clinical phenotypes and that may show a variety of clinical manifestations such as interaction of genetic, and immunological and environmental factors. Plaque-type psoriasis (PP) is the most common form of psoriasis, occurring in 85%–90% of all cases. The classical symptoms of PP correspond to Ekakushtha in ayurveda, which is explained under Kushtha (skin) disease. The clinical sign and symptoms, dermatological examination, and previous history confirmed the case as “Plaque psoriasis.” According to classics, the case was diagnosed as Ekakushtha. Internal administration of decoction of drugs Punarnava, Manjistha, and Ushira, and Arogyavardhini Vati along with local application of 777 oil and Jivantyadi Yamaka was suggested to the patient initially for 1 month. After 1 month of treatment, there was a significant improvement in subjective assessment of itching, scaling, dryness, and erythema and PASI score, which was initially 43.6, was reduced to 5.2. Then along with above medication Mahatikta Ghrita was prescribed for 6 months. After 6 months of treatment, there was complete regression of all the symptoms and PASI score was found to be 0. In follow-up period even 10 months without medication, there were no signs of relapse. This case proved efficacy of ayurveda interventions in treating such cases where other systems of medicines have their own limitation.
银屑病是一种慢性炎症性皮肤病,具有不同的临床表型,可能表现出多种临床表现,如遗传、免疫和环境因素的相互作用。斑块型牛皮癣(PP)是最常见的牛皮癣,占所有病例的85%-90%。PP的经典症状对应于阿育吠陀中的Ekakushtha,这是在库什塔(皮肤)疾病下解释的。临床体征、症状、皮肤科检查及既往病史均证实为“斑块型银屑病”。根据经典,这种情况被诊断为Ekakushtha。建议患者先内服普那那、曼吉沙、乌什拉、阿罗伽梵尼等药物煎剂,局部应用777油、吉万伽梵山药,疗程1个月。治疗1个月后,瘙痒、结垢、干燥和红斑的主观评估有显著改善,PASI评分从最初的43.6降至5.2。然后与上述药物一起,玛哈提塔·格里塔被开了6个月的处方。治疗6个月后,所有症状均完全消退,PASI评分为0。随访10个月未用药,无复发迹象。这个病例证明了阿育吠陀干预在治疗其他药物系统有其自身局限性的情况下的有效性。
{"title":"Ayurveda interventions in management of chronic plaque psoriasis (Ekakushtha)","authors":"Meenakshi Sharma, S. Mandal, Anil Kumar","doi":"10.4103/jism.jism_62_21","DOIUrl":"https://doi.org/10.4103/jism.jism_62_21","url":null,"abstract":"Psoriasis is a chronic inflammatory disease skin disease that is associated with different clinical phenotypes and that may show a variety of clinical manifestations such as interaction of genetic, and immunological and environmental factors. Plaque-type psoriasis (PP) is the most common form of psoriasis, occurring in 85%–90% of all cases. The classical symptoms of PP correspond to Ekakushtha in ayurveda, which is explained under Kushtha (skin) disease. The clinical sign and symptoms, dermatological examination, and previous history confirmed the case as “Plaque psoriasis.” According to classics, the case was diagnosed as Ekakushtha. Internal administration of decoction of drugs Punarnava, Manjistha, and Ushira, and Arogyavardhini Vati along with local application of 777 oil and Jivantyadi Yamaka was suggested to the patient initially for 1 month. After 1 month of treatment, there was a significant improvement in subjective assessment of itching, scaling, dryness, and erythema and PASI score, which was initially 43.6, was reduced to 5.2. Then along with above medication Mahatikta Ghrita was prescribed for 6 months. After 6 months of treatment, there was complete regression of all the symptoms and PASI score was found to be 0. In follow-up period even 10 months without medication, there were no signs of relapse. This case proved efficacy of ayurveda interventions in treating such cases where other systems of medicines have their own limitation.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"31 1","pages":"278 - 283"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81047591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Event report on post graduate induction programme 研究生入职计划活动报告
Pub Date : 2021-10-01 DOI: 10.4103/jism.jism_28_21
Priyanka Shelotkar
{"title":"Event report on post graduate induction programme","authors":"Priyanka Shelotkar","doi":"10.4103/jism.jism_28_21","DOIUrl":"https://doi.org/10.4103/jism.jism_28_21","url":null,"abstract":"","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"47 1","pages":"284 - 285"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80706516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurveda approach to mucormycosis and other fungal infections: A comprehensive review 阿育吠陀治疗毛霉病和其他真菌感染的方法:全面回顾
Pub Date : 2021-10-01 DOI: 10.4103/jism.jism_47_21
Kasimadom Karthik, A. Dileep, S. Rajagopala, A. Mahapatra, Prasanth Dharmarajan
Introduction: Mucormycosis is an opportunistic angio-fungal infection that has resurfaced during the COVID-19 pandemic period due to multifarious reasons. Due to the limitations of current interventions associated with it, prevention is the recommended strategy. Ayurveda has a significant role to play in prevention, for which prior understanding of the condition in its own parlance is essential. Materials and Methods: Literature and research works from Ayurveda and Western biomedicine relevant to the subject were identified, screened, explored, and interpreted. The data obtained were grouped into three major criteria: etiological factors, disease patterns, and disease targets. These ideas were grouped to obtain a near-total picture of mucormycosis. A set of recommendations, including diet, regimen, single drugs, formulations, therapeutic procedures, and community-level interventions, were made on the basis of research evidence and textual indications. Results and Discussion: Mucormycosis is an exogenous condition that initially follows a common pathogenetic pattern, localizing at various sites to show diverging manifestations. Kapha and Pitta (especially in terms of Snigdha and Uṣṇa properties) play a major role in preventive and curative strategies in terms of food, regimen, medicine, and therapies. Conclusion: The current Ayurveda knowledge should be effectively used in diagnosing, staging, preventing, and rehabilitating the cases of mucormycoses. Their curative role as adjuvant and standalone therapies are to be subjected to further research.
毛霉菌病是一种机会性血管真菌感染,在COVID-19大流行期间由于多种原因重新出现。由于目前与之相关的干预措施的局限性,建议采取预防策略。阿育吠陀在预防方面发挥着重要作用,因此事先了解其自身的说法是至关重要的。材料和方法:从阿育吠陀和西方生物医学相关的文献和研究工作进行鉴定、筛选、探索和解释。获得的数据分为三个主要标准:病因、疾病模式和疾病靶点。这些想法被分组,以获得毛霉病的近全貌。在研究证据和文献适应症的基础上,提出了一系列建议,包括饮食、方案、单一药物、配方、治疗程序和社区一级干预措施。结果和讨论:毛霉病是一种外源性疾病,最初遵循共同的发病模式,在不同部位定位,表现出不同的表现。Kapha和Pitta(特别是在Snigdha和Uṣṇa属性方面)在食物、养生、药物和治疗方面的预防和治疗策略中发挥着重要作用。结论:现有的阿育吠陀医学知识应有效应用于毛霉菌病的诊断、分期、预防和康复。它们作为辅助和独立治疗的治疗作用有待进一步研究。
{"title":"Ayurveda approach to mucormycosis and other fungal infections: A comprehensive review","authors":"Kasimadom Karthik, A. Dileep, S. Rajagopala, A. Mahapatra, Prasanth Dharmarajan","doi":"10.4103/jism.jism_47_21","DOIUrl":"https://doi.org/10.4103/jism.jism_47_21","url":null,"abstract":"Introduction: Mucormycosis is an opportunistic angio-fungal infection that has resurfaced during the COVID-19 pandemic period due to multifarious reasons. Due to the limitations of current interventions associated with it, prevention is the recommended strategy. Ayurveda has a significant role to play in prevention, for which prior understanding of the condition in its own parlance is essential. Materials and Methods: Literature and research works from Ayurveda and Western biomedicine relevant to the subject were identified, screened, explored, and interpreted. The data obtained were grouped into three major criteria: etiological factors, disease patterns, and disease targets. These ideas were grouped to obtain a near-total picture of mucormycosis. A set of recommendations, including diet, regimen, single drugs, formulations, therapeutic procedures, and community-level interventions, were made on the basis of research evidence and textual indications. Results and Discussion: Mucormycosis is an exogenous condition that initially follows a common pathogenetic pattern, localizing at various sites to show diverging manifestations. Kapha and Pitta (especially in terms of Snigdha and Uṣṇa properties) play a major role in preventive and curative strategies in terms of food, regimen, medicine, and therapies. Conclusion: The current Ayurveda knowledge should be effectively used in diagnosing, staging, preventing, and rehabilitating the cases of mucormycoses. Their curative role as adjuvant and standalone therapies are to be subjected to further research.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"16 1","pages":"216 - 225"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75417376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Review of clinical and preclinical studies on Ayurveda drugs used in management of liver diseases: A search for proof of concept 阿育吠陀药物用于肝脏疾病管理的临床和临床前研究综述:寻找概念证明
Pub Date : 2021-10-01 DOI: 10.4103/jism.jism_60_21
Bhavana Sharma, Meenakshi Sharma, Shalini Rai, A. More
Introduction: Liver disease has become a matter of public health concern. The worldwide prevalence of liver disease is rapidly increasing due to changes in our cultural and lifestyle norms. Western medicine is known to have serious adverse effects in patients with liver disease. Ayurveda is enriched with various herbo-mineral formulations and their efficacy and safety in treating liver disease has been evidenced in various forms of research. This potential of Ayurveda formulation can be utilized to treat liver disease. The present review is aiming at summarizing a well-organized and comprehensive analysis of various clinical and cell line studies using Ayurveda hepato-protective drugs. Materials and Methods: A thorough search was conducted in online databases of Google Scholar and PubMed on Ayurveda and modern drugs acting in liver disorders. Studies meeting our selection criteria were included and evaluated. Observations and Results: Eighty-six relevant articles were found, of which 55 were used in this review. Conclusions: Ayurveda drugs have been used for centuries in liver diseases of varied etiology. In this systematic analysis, a detailed description of reviewed studies on hepato-protective plants clearly indicates the efficacy and safety of widely used medicinal drugs used in alleviating chronic liver disease and that have an enormous potential to protect the liver from oxidative injury. It is inferred from the study that Ayurveda formulations can be used to combat various liver diseases both safely and efficiently.
肝病已成为公共卫生关注的问题。由于我们的文化和生活方式规范的改变,世界范围内肝病的患病率正在迅速增加。众所周知,西药对肝病患者有严重的副作用。阿育吠陀富含各种草药矿物质配方,其治疗肝脏疾病的功效和安全性已在各种形式的研究中得到证明。阿育吠陀配方的这种潜力可以用来治疗肝脏疾病。本综述旨在总结一个组织良好的综合分析各种临床和细胞系研究使用阿育吠陀保肝药物。材料和方法:在Google Scholar和PubMed的在线数据库中对阿育吠陀和现代肝脏疾病药物进行了彻底的搜索。符合我们选择标准的研究被纳入并评估。观察与结果:共发现86篇相关文献,其中55篇被纳入本综述。结论:几个世纪以来,阿育吠陀药物一直用于治疗各种病因的肝脏疾病。在这篇系统的分析中,对肝脏保护植物的研究综述进行了详细的描述,清楚地指出了广泛用于缓解慢性肝病的药物的有效性和安全性,并具有保护肝脏免受氧化损伤的巨大潜力。从研究中可以推断,阿育吠陀配方可以安全有效地用于对抗各种肝脏疾病。
{"title":"Review of clinical and preclinical studies on Ayurveda drugs used in management of liver diseases: A search for proof of concept","authors":"Bhavana Sharma, Meenakshi Sharma, Shalini Rai, A. More","doi":"10.4103/jism.jism_60_21","DOIUrl":"https://doi.org/10.4103/jism.jism_60_21","url":null,"abstract":"Introduction: Liver disease has become a matter of public health concern. The worldwide prevalence of liver disease is rapidly increasing due to changes in our cultural and lifestyle norms. Western medicine is known to have serious adverse effects in patients with liver disease. Ayurveda is enriched with various herbo-mineral formulations and their efficacy and safety in treating liver disease has been evidenced in various forms of research. This potential of Ayurveda formulation can be utilized to treat liver disease. The present review is aiming at summarizing a well-organized and comprehensive analysis of various clinical and cell line studies using Ayurveda hepato-protective drugs. Materials and Methods: A thorough search was conducted in online databases of Google Scholar and PubMed on Ayurveda and modern drugs acting in liver disorders. Studies meeting our selection criteria were included and evaluated. Observations and Results: Eighty-six relevant articles were found, of which 55 were used in this review. Conclusions: Ayurveda drugs have been used for centuries in liver diseases of varied etiology. In this systematic analysis, a detailed description of reviewed studies on hepato-protective plants clearly indicates the efficacy and safety of widely used medicinal drugs used in alleviating chronic liver disease and that have an enormous potential to protect the liver from oxidative injury. It is inferred from the study that Ayurveda formulations can be used to combat various liver diseases both safely and efficiently.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"57 1","pages":"226 - 234"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83556846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Geriatric care in pandemic era: From the perspective of Unani medicine guidelines 大流行时期的老年保健:从乌干达医学指南的角度看
Pub Date : 2021-10-01 DOI: 10.4103/jism.jism_44_21
S. Ahmer, M. Amin, A. Fahad
Background: Elderly people are at a greater risk of developing COVID-19. They are facing the most challenges during the pandemic era because of preexisting medical conditions (such as diabetes mellitus, cardiovascular diseases, pulmonary diseases, or neoplasm). As per the first longitudinal aging study (LASI) in India released by the Union Ministry of Family and Health Welfare on 6 January 2020, two out of every three senior citizens in India are suffering from some chronic diseases. Considering the fact that the elderly are at a higher risk of serious complications and mortality with COVID-19, dietotherapy and other regimenal therapy guidelines described by Unani physicians can possibly play a significant interventional role against COVID-19 by improving the general body condition. Aim of Study: The primary aim of this review paper is to organize all reliable literary resources in Unani medicine regarding geriatric care to make geriatric age groups safe and secure during this pandemic. Materials and Methods: This review study of geriatric care was carried out with the aid of the Unani classical textbooks and the research updates on geriatric care, aging, dietotherapy, and regimenal therapy that were retrieved from PubMed, Google Scholar, and ResearchGate. Observation and Results: The information given by Unani physicians in ancient times has proved to be very useful and authentic to overcome this pandemic. In today’s research, modern theories and inventions also validate and accept the relevance of all the recommendations or practices given by Unani physicians. Conclusion: This entire article focuses on the recommendations of Unani medicine for geriatric care. Dietotherapy and other regimenal therapy described in this article can possibly play a significant interventional role against COVID-19 by improving the general body condition.
背景:老年人患COVID-19的风险更大。由于先前存在的疾病(如糖尿病、心血管疾病、肺部疾病或肿瘤),他们在大流行时期面临的挑战最大。根据联邦家庭和卫生福利部于2020年1月6日发布的印度首个纵向老龄化研究(LASI),印度每三个老年人中就有两个患有某些慢性疾病。考虑到老年人患COVID-19严重并发症和死亡的风险更高,乌干达医生描述的饮食疗法和其他方案治疗指南可能会通过改善一般身体状况来发挥重要的干预作用。研究目的:本综述的主要目的是整理乌干达医学中有关老年护理的所有可靠文献资源,以使老年年龄组在本次大流行期间安全可靠。材料与方法:本研究采用Unani经典教科书以及PubMed、Google Scholar和ResearchGate检索到的有关老年护理、衰老、饮食治疗和方案治疗的最新研究成果,对老年护理进行回顾性研究。观察和结果:事实证明,古代乌纳尼医生提供的信息对克服这一流行病非常有用和真实。在今天的研究中,现代理论和发明也证实并接受了Unani医生提出的所有建议或做法的相关性。结论:本文主要介绍乌纳尼药对老年护理的推荐。本文所述的饮食疗法和其他方案疗法可能通过改善一般身体状况,对COVID-19发挥重要的干预作用。
{"title":"Geriatric care in pandemic era: From the perspective of Unani medicine guidelines","authors":"S. Ahmer, M. Amin, A. Fahad","doi":"10.4103/jism.jism_44_21","DOIUrl":"https://doi.org/10.4103/jism.jism_44_21","url":null,"abstract":"Background: Elderly people are at a greater risk of developing COVID-19. They are facing the most challenges during the pandemic era because of preexisting medical conditions (such as diabetes mellitus, cardiovascular diseases, pulmonary diseases, or neoplasm). As per the first longitudinal aging study (LASI) in India released by the Union Ministry of Family and Health Welfare on 6 January 2020, two out of every three senior citizens in India are suffering from some chronic diseases. Considering the fact that the elderly are at a higher risk of serious complications and mortality with COVID-19, dietotherapy and other regimenal therapy guidelines described by Unani physicians can possibly play a significant interventional role against COVID-19 by improving the general body condition. Aim of Study: The primary aim of this review paper is to organize all reliable literary resources in Unani medicine regarding geriatric care to make geriatric age groups safe and secure during this pandemic. Materials and Methods: This review study of geriatric care was carried out with the aid of the Unani classical textbooks and the research updates on geriatric care, aging, dietotherapy, and regimenal therapy that were retrieved from PubMed, Google Scholar, and ResearchGate. Observation and Results: The information given by Unani physicians in ancient times has proved to be very useful and authentic to overcome this pandemic. In today’s research, modern theories and inventions also validate and accept the relevance of all the recommendations or practices given by Unani physicians. Conclusion: This entire article focuses on the recommendations of Unani medicine for geriatric care. Dietotherapy and other regimenal therapy described in this article can possibly play a significant interventional role against COVID-19 by improving the general body condition.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"8 1","pages":"235 - 241"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78097510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Efficacy of palliative herbal decoction (Darvyadi Kwatha) with lifestyle modification in the management of prediabetes (Prameha): a single-arm clinical trial 姑息性中药汤剂(Darvyadi Kwatha)配合生活方式改变治疗前驱糖尿病(Prameha)的疗效:一项单臂临床试验
Pub Date : 2021-10-01 DOI: 10.4103/jism.jism_11_21
U. Yadav, Santosh Bhatted
Background: Prediabetes is a pathological condition that is characterized by an increase in sugar level within the normal limit and a diagnostic range of diabetes mellitus (DM). Timely untreated prediabetes turns into DM within a year and systemic complications occur, such as retinopathy, nephropathy, neuropathy, etc. During later stages of the disease, all systems of the body are affected. The management of prediabetes includes oral hypoglycemic drugs. Based on signs and symptoms, prediabetes can be correlated to the disease Prameha. Aim and Objectives: Evaluate the efficacy of oral administration of Darvyadi Kwatha (~herbal decoction) with lifestyle modification in prediabetes (Prameha).Materials and Methods: After the approval of Institutional Review Board, Independent Ethics Committee, and clinical trial registration in CTRI, 20 patients suffering with Prameha (~prediabetes) were registered in the clinical trial. Assessment criteria were: reduction in glycated hemoglobin (HBA1c), fasting plasma glucose (FBS), postprandial plasma glucose (PPBS), improvement in Agnibala (~strength of digestion and metabolism), Dehabala (~physical strength), and Satvabala (~mental strength), relief in signs and symptoms of prediabetes, and improvement in quality of life (SF-36 Score). Oral administration of Darvyadi Kwatha and lifestyle modification was given. Assessment was done on the 46th, 76th, 107th, and 120th day and Student paired t-test was used for analysis of data. Results: The outcomes showed a statistically highly significant reduction in assessment parameters (HBA1c [mean ± standard deviation [SD] before treatment [BT] 6.07 ± 0.26 and after treatment [AT] 5.78 ± 0.22] [<0.001], FBS [mean ± SD BT 116.6 ± 12.5 and AT 102.0 ± 0.8.1] [<0.001], and PPBS [mean ± SD BT 168.7 ± 19.7 and AT 118.6 ± 12.0] [<0.001]). Conclusion: This clinical study concludes that Ayurveda medicine (Darvyadi Kwatha and lifestyle modification) is effective in the treatment and prevention of prediabetes turning into DM.
背景:糖尿病前期是一种以血糖水平在正常范围内升高为特征的病理状态,属于糖尿病(DM)的诊断范围。未经及时治疗的前驱糖尿病在一年内转变为糖尿病,并出现视网膜病变、肾病、神经病变等全身性并发症。在疾病的后期阶段,身体的所有系统都会受到影响。糖尿病前期的治疗包括口服降糖药。根据体征和症状,前驱糖尿病可能与Prameha相关。目的与目的:评价口服达维地瓜沙汤伴生活方式改变治疗前驱糖尿病(Prameha)的疗效。材料和方法:经机构审查委员会、独立伦理委员会批准,并在CTRI注册临床试验,20例Prameha(~前体糖尿病)患者注册参加临床试验。评估标准为:糖化血红蛋白(HBA1c)、空腹血糖(FBS)、餐后血糖(PPBS)降低,Agnibala(消化代谢能力)、Dehabala(体力)、Satvabala(精神力量)改善,前驱糖尿病体征和症状缓解,生活质量改善(SF-36评分)。口服达维雅地瓜达并改变生活方式。分别于第46、76、107、120天进行评估,采用配对t检验对数据进行分析。结果:结果显示,两组患者的评估参数(治疗前HBA1c [mean±standard deviation [SD]] [BT] 6.07±0.26,治疗后[AT] 5.78±0.22][<0.001],FBS [mean±SD BT 116.6±12.5,AT 102.0±0.8.1][<0.001],PPBS [mean±SD BT 168.7±19.7,AT 118.6±12.0][<0.001])均有显著降低。结论:阿育吠陀药物(Darvyadi Kwatha和生活方式改变)治疗和预防糖尿病前期转化为糖尿病是有效的。
{"title":"Efficacy of palliative herbal decoction (Darvyadi Kwatha) with lifestyle modification in the management of prediabetes (Prameha): a single-arm clinical trial","authors":"U. Yadav, Santosh Bhatted","doi":"10.4103/jism.jism_11_21","DOIUrl":"https://doi.org/10.4103/jism.jism_11_21","url":null,"abstract":"Background: Prediabetes is a pathological condition that is characterized by an increase in sugar level within the normal limit and a diagnostic range of diabetes mellitus (DM). Timely untreated prediabetes turns into DM within a year and systemic complications occur, such as retinopathy, nephropathy, neuropathy, etc. During later stages of the disease, all systems of the body are affected. The management of prediabetes includes oral hypoglycemic drugs. Based on signs and symptoms, prediabetes can be correlated to the disease Prameha. Aim and Objectives: Evaluate the efficacy of oral administration of Darvyadi Kwatha (~herbal decoction) with lifestyle modification in prediabetes (Prameha).Materials and Methods: After the approval of Institutional Review Board, Independent Ethics Committee, and clinical trial registration in CTRI, 20 patients suffering with Prameha (~prediabetes) were registered in the clinical trial. Assessment criteria were: reduction in glycated hemoglobin (HBA1c), fasting plasma glucose (FBS), postprandial plasma glucose (PPBS), improvement in Agnibala (~strength of digestion and metabolism), Dehabala (~physical strength), and Satvabala (~mental strength), relief in signs and symptoms of prediabetes, and improvement in quality of life (SF-36 Score). Oral administration of Darvyadi Kwatha and lifestyle modification was given. Assessment was done on the 46th, 76th, 107th, and 120th day and Student paired t-test was used for analysis of data. Results: The outcomes showed a statistically highly significant reduction in assessment parameters (HBA1c [mean ± standard deviation [SD] before treatment [BT] 6.07 ± 0.26 and after treatment [AT] 5.78 ± 0.22] [<0.001], FBS [mean ± SD BT 116.6 ± 12.5 and AT 102.0 ± 0.8.1] [<0.001], and PPBS [mean ± SD BT 168.7 ± 19.7 and AT 118.6 ± 12.0] [<0.001]). Conclusion: This clinical study concludes that Ayurveda medicine (Darvyadi Kwatha and lifestyle modification) is effective in the treatment and prevention of prediabetes turning into DM.","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"17 1","pages":"265 - 271"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80976620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coherence of variables in clinical trials of Ayurveda 阿育吠陀临床试验中变量的一致性
Pub Date : 2021-10-01 DOI: 10.4103/jism.jism_96_21
Srihari Sheshagiri
{"title":"Coherence of variables in clinical trials of Ayurveda","authors":"Srihari Sheshagiri","doi":"10.4103/jism.jism_96_21","DOIUrl":"https://doi.org/10.4103/jism.jism_96_21","url":null,"abstract":"","PeriodicalId":16051,"journal":{"name":"Journal of Indian System of Medicine","volume":"49 3","pages":"213 - 215"},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91480929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Indian System of Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1